世界の腎芽細胞腫の治療市場：市場規模・現状・予測

• 英文タイトル：Global Nephroblastoma Treatment Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9N7641
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、99ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当資料は、腎芽細胞腫の治療のグローバル市場について調査・分析したレポートで、種類別（良好な組織学、好ましくない組織学）、用途別（病院、がんセンター、手術センター、外来手術センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・腎芽細胞腫の治療の世界市場規模
・主要企業別市場シェア
・腎芽細胞腫の治療の世界市場規模：種類別（良好な組織学、好ましくない組織学）
・腎芽細胞腫の治療の世界市場規模：用途別（病院、がんセンター、手術センター、外来手術センター）
・腎芽細胞腫の治療のアメリカ市場規模（種類別、用途別）
・腎芽細胞腫の治療のヨーロッパ市場規模（種類別、用途別）
・腎芽細胞腫の治療の中国市場規模（種類別、用途別）
・腎芽細胞腫の治療の日本市場規模（種類別、用途別）
・腎芽細胞腫の治療の東南アジア市場規模（種類別、用途別）
・腎芽細胞腫の治療のインド市場規模（種類別、用途別）
・腎芽細胞腫の治療の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・腎芽細胞腫の治療の世界市場予測（2019年-2025年）
・腎芽細胞腫の治療の地域別市場予測（2019年-2025年）
...

Nephroblastoma is a cancer of the kidneys that typically occurs in children, rarely in adults. Approximately 500 cases are diagnosed in the U.S. annually. The majority (75%) occurs in otherwise normal children; a minority (25%) is associated with other developmental abnormalities. It is highly responsive to treatment, with about 90% of patients surviving at least five years.The overall 5-year survival is estimated to be approximately 90%, but for individuals the prognosis is highly dependent on individual staging and treatment. Early removal tends to promote positive outcomes.
In 2018, the global Nephroblastoma Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Nephroblastoma Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Nephroblastoma Treatment development in United States, Europe and China.

The key players covered in this study
Bayer HealthCare
Roche
Pfizer
Sanofi Pasteur
Merck
MediLexicon
Bristol-Myers Squibb Company
Apotex

Market segment by Type, the product can be split into
Favorable Histology
Unfavorable Histology

Market segment by Application, split into
Hospitals
Cancer Centers
Surgical Centers
Ambulatory Surgical Center

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Nephroblastoma Treatment status, future forecast, growth opportunity, key market and key players.
To present the Nephroblastoma Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Nephroblastoma Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Nephroblastoma Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Favorable Histology
1.4.3 Unfavorable Histology
1.5 Market by Application
1.5.1 Global Nephroblastoma Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Cancer Centers
1.5.4 Surgical Centers
1.5.5 Ambulatory Surgical Center
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Nephroblastoma Treatment Market Size
2.2 Nephroblastoma Treatment Growth Trends by Regions
2.2.1 Nephroblastoma Treatment Market Size by Regions (2014-2025)
2.2.2 Nephroblastoma Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Nephroblastoma Treatment Market Size by Manufacturers
3.1.1 Global Nephroblastoma Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Nephroblastoma Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Nephroblastoma Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Nephroblastoma Treatment Key Players Head office and Area Served
3.3 Key Players Nephroblastoma Treatment Product/Solution/Service
3.4 Date of Enter into Nephroblastoma Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Nephroblastoma Treatment Market Size by Type (2014-2019)
4.2 Global Nephroblastoma Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Nephroblastoma Treatment Market Size (2014-2019)
5.2 Nephroblastoma Treatment Key Players in United States
5.3 United States Nephroblastoma Treatment Market Size by Type
5.4 United States Nephroblastoma Treatment Market Size by Application

6 Europe
6.1 Europe Nephroblastoma Treatment Market Size (2014-2019)
6.2 Nephroblastoma Treatment Key Players in Europe
6.3 Europe Nephroblastoma Treatment Market Size by Type
6.4 Europe Nephroblastoma Treatment Market Size by Application

7 China
7.1 China Nephroblastoma Treatment Market Size (2014-2019)
7.2 Nephroblastoma Treatment Key Players in China
7.3 China Nephroblastoma Treatment Market Size by Type
7.4 China Nephroblastoma Treatment Market Size by Application

8 Japan
8.1 Japan Nephroblastoma Treatment Market Size (2014-2019)
8.2 Nephroblastoma Treatment Key Players in Japan
8.3 Japan Nephroblastoma Treatment Market Size by Type
8.4 Japan Nephroblastoma Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Nephroblastoma Treatment Market Size (2014-2019)
9.2 Nephroblastoma Treatment Key Players in Southeast Asia
9.3 Southeast Asia Nephroblastoma Treatment Market Size by Type
9.4 Southeast Asia Nephroblastoma Treatment Market Size by Application

10 India
10.1 India Nephroblastoma Treatment Market Size (2014-2019)
10.2 Nephroblastoma Treatment Key Players in India
10.3 India Nephroblastoma Treatment Market Size by Type
10.4 India Nephroblastoma Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Nephroblastoma Treatment Market Size (2014-2019)
11.2 Nephroblastoma Treatment Key Players in Central & South America
11.3 Central & South America Nephroblastoma Treatment Market Size by Type
11.4 Central & South America Nephroblastoma Treatment Market Size by Application

12 International Players Profiles
12.1 Bayer HealthCare
12.1.1 Bayer HealthCare Company Details
12.1.2 Company Description and Business Overview
12.1.3 Nephroblastoma Treatment Introduction
12.1.4 Bayer HealthCare Revenue in Nephroblastoma Treatment Business (2014-2019)
12.1.5 Bayer HealthCare Recent Development
12.2 Roche
12.2.1 Roche Company Details
12.2.2 Company Description and Business Overview
12.2.3 Nephroblastoma Treatment Introduction
12.2.4 Roche Revenue in Nephroblastoma Treatment Business (2014-2019)
12.2.5 Roche Recent Development
12.3 Pfizer
12.3.1 Pfizer Company Details
12.3.2 Company Description and Business Overview
12.3.3 Nephroblastoma Treatment Introduction
12.3.4 Pfizer Revenue in Nephroblastoma Treatment Business (2014-2019)
12.3.5 Pfizer Recent Development
12.4 Sanofi Pasteur
12.4.1 Sanofi Pasteur Company Details
12.4.2 Company Description and Business Overview
12.4.3 Nephroblastoma Treatment Introduction
12.4.4 Sanofi Pasteur Revenue in Nephroblastoma Treatment Business (2014-2019)
12.4.5 Sanofi Pasteur Recent Development
12.5 Merck
12.5.1 Merck Company Details
12.5.2 Company Description and Business Overview
12.5.3 Nephroblastoma Treatment Introduction
12.5.4 Merck Revenue in Nephroblastoma Treatment Business (2014-2019)
12.5.5 Merck Recent Development
12.6 MediLexicon
12.6.1 MediLexicon Company Details
12.6.2 Company Description and Business Overview
12.6.3 Nephroblastoma Treatment Introduction
12.6.4 MediLexicon Revenue in Nephroblastoma Treatment Business (2014-2019)
12.6.5 MediLexicon Recent Development
12.7 Bristol-Myers Squibb Company
12.7.1 Bristol-Myers Squibb Company Company Details
12.7.2 Company Description and Business Overview
12.7.3 Nephroblastoma Treatment Introduction
12.7.4 Bristol-Myers Squibb Company Revenue in Nephroblastoma Treatment Business (2014-2019)
12.7.5 Bristol-Myers Squibb Company Recent Development
12.8 Apotex
12.8.1 Apotex Company Details
12.8.2 Company Description and Business Overview
12.8.3 Nephroblastoma Treatment Introduction
12.8.4 Apotex Revenue in Nephroblastoma Treatment Business (2014-2019)
12.8.5 Apotex Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Nephroblastoma Treatment Key Market Segments
Table Key Players Nephroblastoma Treatment Covered
Table Global Nephroblastoma Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Nephroblastoma Treatment Market Size Market Share by Type 2014-2025
Figure Favorable Histology Figures
Table Key Players of Favorable Histology
Figure Unfavorable Histology Figures
Table Key Players of Unfavorable Histology
Table Global Nephroblastoma Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Cancer Centers Case Studies
Figure Surgical Centers Case Studies
Figure Ambulatory Surgical Center Case Studies
Figure Nephroblastoma Treatment Report Years Considered
Table Global Nephroblastoma Treatment Market Size 2014-2025 (Million US$)
Figure Global Nephroblastoma Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Nephroblastoma Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Nephroblastoma Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Nephroblastoma Treatment Market Share by Regions 2014-2019
Figure Global Nephroblastoma Treatment Market Share by Regions 2014-2019
Figure Global Nephroblastoma Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Nephroblastoma Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Nephroblastoma Treatment Market Share by Manufacturers (2014-2019)
Figure Global Nephroblastoma Treatment Market Share by Manufacturers in 2018
Table Global Nephroblastoma Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Nephroblastoma Treatment Product/Solution/Service
Table Date of Enter into Nephroblastoma Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Nephroblastoma Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Nephroblastoma Treatment Market Size Share by Type (2014-2019)
Figure Global Nephroblastoma Treatment Market Size Market Share by Type (2014-2019)
Table Global Nephroblastoma Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Nephroblastoma Treatment Market Size Share by Application (2014-2019)
Figure Global Nephroblastoma Treatment Market Size Market Share by Application (2014-2019)
Figure Global Nephroblastoma Treatment Revenue Market Share by Application in 2018
Figure United States Nephroblastoma Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Nephroblastoma Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Nephroblastoma Treatment Market Share (2018-2019)
Table United States Nephroblastoma Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Nephroblastoma Treatment Market Share by Type (2014-2019)
Table United States Nephroblastoma Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Nephroblastoma Treatment Market Share by Application (2014-2019)
Figure Europe Nephroblastoma Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Nephroblastoma Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Nephroblastoma Treatment Market Share (2018-2019)
Table Europe Nephroblastoma Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Nephroblastoma Treatment Market Share by Type (2014-2019)
Table Europe Nephroblastoma Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Nephroblastoma Treatment Market Share by Application (2014-2019)
Figure China Nephroblastoma Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Nephroblastoma Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Nephroblastoma Treatment Market Share (2018-2019)
Table China Nephroblastoma Treatment Market Size by Type (2014-20189) (Million US$)
Table China Nephroblastoma Treatment Market Share by Type (2014-2019)
Table China Nephroblastoma Treatment Market Size by Application (2014-2019) (Million US$)
Table China Nephroblastoma Treatment Market Share by Application (2014-2019)
Figure Japan Nephroblastoma Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Nephroblastoma Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Nephroblastoma Treatment Market Share (2018-2019)
Table Japan Nephroblastoma Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Nephroblastoma Treatment Market Share by Type (2014-2019)
Table Japan Nephroblastoma Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Nephroblastoma Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Nephroblastoma Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Nephroblastoma Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Nephroblastoma Treatment Market Share (2018-2019)
Table Southeast Asia Nephroblastoma Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Nephroblastoma Treatment Market Share by Type (2014-2019)
Table Southeast Asia Nephroblastoma Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Nephroblastoma Treatment Market Share by Application (2014-2019)
Figure India Nephroblastoma Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Nephroblastoma Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Nephroblastoma Treatment Market Share (2018-2019)
Table India Nephroblastoma Treatment Market Size by Type (2014-2019) (Million US$)
Table India Nephroblastoma Treatment Market Share by Type (2014-2019)
Table India Nephroblastoma Treatment Market Size by Application (2014-2019) (Million US$)
Table India Nephroblastoma Treatment Market Share by Application (2014-2019)
Figure Central & South America Nephroblastoma Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Nephroblastoma Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Nephroblastoma Treatment Market Share (2018-2019)
Table Central & South America Nephroblastoma Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Nephroblastoma Treatment Market Share by Type (2014-2019)
Table Central & South America Nephroblastoma Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Nephroblastoma Treatment Market Share by Application (2014-2019)
Table Bayer HealthCare Company Details
Table Bayer HealthCare Revenue in Nephroblastoma Treatment Business (2014-2019) (Million US$)
Figure Bayer HealthCare Revenue Growth Rate in Nephroblastoma Treatment Business (2014-2019)
Table Bayer HealthCare Recent Development
Table Roche Company Details
Table Roche Revenue in Nephroblastoma Treatment Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Nephroblastoma Treatment Business (2014-2019)
Table Roche Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Nephroblastoma Treatment Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Nephroblastoma Treatment Business (2014-2019)
Table Pfizer Recent Development
Table Sanofi Pasteur Company Details
Table Sanofi Pasteur Revenue in Nephroblastoma Treatment Business (2014-2019)(Million US$)
Figure Sanofi Pasteur Revenue Growth Rate in Nephroblastoma Treatment Business (2014-2019)
Table Sanofi Pasteur Recent Development
Table Merck Company Details
Table Merck Revenue in Nephroblastoma Treatment Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Nephroblastoma Treatment Business (2014-2019)
Table Merck Recent Development
Table MediLexicon Company Details
Table MediLexicon Revenue in Nephroblastoma Treatment Business (2014-2019)(Million US$)
Figure MediLexicon Revenue Growth Rate in Nephroblastoma Treatment Business (2014-2019)
Table MediLexicon Recent Development
Table Bristol-Myers Squibb Company Company Details
Table Bristol-Myers Squibb Company Revenue in Nephroblastoma Treatment Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Company Revenue Growth Rate in Nephroblastoma Treatment Business (2014-2019)
Table Bristol-Myers Squibb Company Recent Development
Table Apotex Company Details
Table Apotex Revenue in Nephroblastoma Treatment Business (2014-2019)(Million US$)
Figure Apotex Revenue Growth Rate in Nephroblastoma Treatment Business (2014-2019)
Table Apotex Recent Development
Table Global Nephroblastoma Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Nephroblastoma Treatment Market Size Share by Regions (2019-2025)
Figure Global Nephroblastoma Treatment Market Size Share by Regions in 2025
Figure United States Nephroblastoma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Nephroblastoma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Nephroblastoma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Nephroblastoma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Nephroblastoma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Nephroblastoma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Nephroblastoma Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Nephroblastoma Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Nephroblastoma Treatment Market Size by Product (2019-2025)
Figure Global Nephroblastoma Treatment Market Size by Product in 2025
Table Global Nephroblastoma Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Nephroblastoma Treatment Market Size by Application (2019-2025)
Figure Global Nephroblastoma Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

世界の腱炎治療市場：市場規模・現状・予測

Global Tendinitis Treatment Market Size, Status and Forecast 2019-2025
QYR9N8111 2019年6月14日 93Pages
当資料は、腱炎治療のグローバル市場について調査・分析したレポートで、種類別（薬、手術療法、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・腱炎治療...

世界のポロ角化症の治療市場：市場規模・現状・予測

Global Porokeratosis Treatment Market Size, Status and Forecast 2019-2025
QYR9N7861 2019年6月14日 109Pages
当資料は、ポロ角化症の治療のグローバル市場について調査・分析したレポートで、種類別（薬、光線力学療法、凍結療法、レーザー、その他）、用途別（病院、診療所、診断センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれて...

世界の感覚異常の治療市場：市場規模・現状・予測

Global Paresthesia Treatment Market Size, Status and Forecast 2019-2025
QYR9N7765 2019年6月14日 96Pages
当資料は、感覚異常の治療のグローバル市場について調査・分析したレポートで、種類別（急性感覚異常、慢性感覚異常）、用途別（病院、診療所、診断センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

世界の髄膜炎菌感染症の治療市場：市場規模・現状・予測

Global Meningococcal Infections Treatment Market Size, Status and Forecast 2019-2025
QYR9N7541 2019年6月14日 94Pages
当資料は、髄膜炎菌感染症の治療のグローバル市場について調査・分析したレポートで、種類別（抗生物質、グルココルチコイド、プロテインC濃縮物）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています...

世界の下垂体の治療市場：市場規模・現状・予測

Global Hypodontia Treatment Market Size, Status and Forecast 2019-2025
QYR9N7329 2019年6月14日 93Pages
当資料は、下垂体の治療のグローバル市場について調査・分析したレポートで、種類別（修復歯科、歯列矯正、口腔外科、その他）、用途別（病院、歯科医院、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
<...

世界のHIVの診断と治療市場：市場規模・現状・予測

Global HIV Diagnosis and Treatment Market Size, Status and Forecast 2019-2025
QYR9N7303 2019年6月14日 95Pages
当資料は、HIVの診断と治療のグローバル市場について調査・分析したレポートで、種類別（抗体検査、ウイルス同定アッセイ、Cd4テスト、ウイルス負荷試験、早期乳児診断）、用途別（診断研究所、病院、血液銀行、在宅ケアの設定）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場...

世界の汗腺炎掻爬治療市場：市場規模・現状・予測

Global Hidradenitis Suppurativa Treatment Market Size, Status and Forecast 2019-2025
QYR9N7295 2019年6月14日 99Pages
当資料は、汗腺炎掻爬治療のグローバル市場について調査・分析したレポートで、種類別（薬、手術、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・汗腺炎...

世界のフォンヴィレブランド病治療市場：市場規模・現状・予測

Global Von Willebrand Disease Treatment Market Size, Status and Forecast 2019-2025
QYR9N8188 2019年6月14日 93Pages
当資料は、フォンヴィレブランド病治療のグローバル市場について調査・分析したレポートで、種類別（ヴェイヴォンディ、フミン酸-P、英数字、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれてい...

世界のディンプル形成術の治療市場：市場規模・現状・予測

Global Dimpleplasty Treatment Market Size, Status and Forecast 2019-2025
QYR9N7109 2019年6月14日 93Pages
当資料は、ディンプル形成術の治療のグローバル市場について調査・分析したレポートで、種類別（光線療法、レーザー治療、その他）、用途別（病院、皮膚科クリニック、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

世界のサイトメガロウイルス治療市場：市場規模・現状・予測

Global Cytomegalovirus Treatment Market Size, Status and Forecast 2019-2025
QYR9N7060 2019年6月14日 97Pages
当資料は、サイトメガロウイルス治療のグローバル市場について調査・分析したレポートで、種類別（ガンシクロビル、バルガンシクロビル、フォスカーネット、シドフォビル、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模...

世界の組織学および細胞診市場：市場規模・現状・予測 In 2018, the global Histology and Cytology market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025. This report focuses on the global Histology and Cytology status, future forecast, growth opportunity, key market and key players. The st…
世界の非黒色腫皮膚がんの治療市場：市場規模・現状・予測 Non-melanoma skin cancer is usually treated as a simple lesion in the initial stages but if not treated properly, it can quickly mushroom and spread to other body parts.Radiation therapy has a market share approaching 88% in the non-melanoma skin cancer treatment market in 2017 itself and is unlikel…
世界の非外科外側上顆炎治療市場：市場規模・現状・予測 The non surgical treatment includes extracorporeal shock wave therapy, braces, medications and physical therapies. Various anti inflammatory drugs (NSAIDS) such as ibuprofen, aspirin and cortisone are administered to control pain in lateral epicondylitis. In 2018, the global Non-surgical Lateral Epi…
世界の外科的外側上顆炎治療市場：市場規模・現状・予測 In Surgical Lateral Epicondylitis Treatment, arthroscopic surgery and open surgery are performed. In 2018, the global Surgical Lateral Epicondylitis Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This repor…
世界の非血液がん治療市場：市場規模・現状・予測 Non-Hematological cancers which cover lung cancer, prostate cancer, breast cancer and others, this type of cancer are not show easily diagnosis and the treatment process is also show long that some time it lead to the death of the patient.North America has the huge number of population suffering fro…